Login / Signup
Follow
Call Us: (+91) 89626-12340
[email protected]
Signup|Login As :
Subscriber
|
Author
|
Reviewer
|
Editor
| Follow Us:
Call Us: +4 (800)
888-0008
Home
+
Journals
Editors
+
Pharmaceutical
Engineering & Technology
Business Management
Health Sciences
Authors
+
Subscribe
+
Contact Us
+
Inventi Impact: Ophthalmology
Home
Editorial Board
Current Issue
Past Issues
Patent Watch
Articles
Inventi:hotm/28125/19
Effects of ranibizumab (Lucentis®) and\nbevacizumab (Avastin®) on human corneal\nendothelial cells
Research
2019 : April - June
Patrick R Merz, Nina Rockel, Seda Ballikaya, Gerd U Auffarth, Ingo Schmack
--NA--
How to Cite this Article
CC Compliant Citation: Merz, Patrick R., et al. \"Effects of ranibizumab (Lucentis®) and bevacizumab (Avastin®) on human corneal\nendothelial cells.\" BMC ophthalmology 18.1 (2018): 316, https://doi.org/10.1186/s12886-018-0978-9, http://\ncreativecommons.org/licenses/by/4.0/.\n87
Download Full Text
Loading....